Comparison of Bevacizumab and Aflibercept in Treatment of Diabetic Macular Edema
Comparison of Bevacizumab and Aflibercept in Treatment of Diabetic Macular Edema
Enrolling by invitation · NCT07338097 · Registry updated 2026-01-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparison of Bevacizumab and Aflibercept in Treatment of Diabetic Macular Edema | Diabetic Macular Edema (DME) | Enrolling by invitation | Not applicable | 2026-01-13 | NCT07338097 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| CMH Multan Institute of Medical Sciences | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CMH Institute of Medical Sciences | Multan | Pakistan | 1 |